Clinical trial NCT03246516: Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers
Official title: Individual and Socio-economic Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Oesophageal Carcinoma
Gastric Adenocarcinoma
Lead sponsor: University Hospital, Lille
Sponsor class: OTHER
Collaborators: name: University of Lille Nord de France
First posted: 2017-08-11
Enrollment: 258
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.

Detailed description: Reducing the time between the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) is essential to improve the vital prognosis and quality of life of patients. Recent data suggest that some sociocognitive and emotional determinants may explain patient delay from a complementary point of view. The main objective of this study is to assess whether, in oeso-gastric cancer, patient delay is linked to these sociocognitive and emotional factors, in addition to previously known factors.

We intend to include in this study 300 patients with a not yet treated oeso-gastric cancer diagnosed in one of 10 health centres in the North of France region. The collected data will be analysed to underline the differences between patients who consulted a doctor earlier versus those who consulted later with a cut off at 8 weeks.

Eligibility criteria: Inclusion Criteria:

* age ≥ 18 years
* oesophageal, oeso-gastric junction or gastric cancer non treated cancer
* patient informed of his diagnosis
* speak fluent french

Exclusion Criteria:

* history of cancer
* psychological history
* patient under guardianship-
* fortuitous diagnosis of cancer

Primary outcomes:
measure: Time limit of first doctor consultation
timeFrame: baseline
Secondary outcomes:
measure: Time limit of system of care
timeFrame: baseline
measure: cTNM Stage
timeFrame: baseline
measure: clinical variables (i.e medical history, symptoms, entry into care pathway)
timeFrame: baseline
measure: Socio-cognitive variables
timeFrame: baseline
measure: Emotional variables
timeFrame: baseline
measure: Survival
timeFrame: At 3 years
Other outcomes:
Locations:
city: Boulogne-sur-Mer
country: France
facility: Centre Hospitalier de Boulogne sur mer
city: Béthune
country: France
facility: Centre hospitalier de Béthune
city: Calais
country: France
facility: Centre hospitalier de Calais
city: Dechy
country: France
facility: centre Léonard de Vinci
city: Dunkerque
country: France
facility: Centre d 'oncologie Dunkerquois
city: Lille
country: France
facility: CHRU, Hôpital Claude Huriez
city: Lille
country: France
facility: Centre oscar Lambret
city: Roubaix
country: France
facility: Centre hospitalier de Roubaix
city: Seclin
country: France
facility: Centre Hospitalier de Seclin
city: Valenciennes
country: France
facility: Centre hospitalier de valenciennes
Study officials:
affiliation: University Hospital, Lille
name: Guillaume Piessen, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References: